BioSpace News Archive

Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced its full support of the Administration’s Advancing American Kidney Health Initiative introduced today.

Altaire Pharmaceuticals, Inc., announces that it is voluntarily recalling the Over-the-Counter drug products and lots, within expiry, sold at CVS Health the during the time period as indicated in the tables below.

The middle ear implants sector has undergone significant technological advancements which have led to an increase in adoption among end-users.

Scientists have identified a new ally in the battle against the deadly outbreak of the superbug Candida auris, currently found in more than 20 countries and likely spreading.

The Pierre Fabre Group, the second largest dermo-cosmetics laboratory in the world and the second largest private French pharmaceutical group, enlisted independent body ECOCERT Environment to assess its CSR (Corporate Social Responsibility) approach according to the ISO 26000 standard on sustainable development.

DaVita Kidney Care appreciates President Trump, the Administration and Secretary Azar for taking steps to improve the lives of kidney patients.

Impel NeuroPharma, a late-stage biopharmaceutical company focused on the development and commercialization of transformative therapies for patients living with central nervous system (CNS) disorders with high unmet medical needs, today announcedthat it will present four scientific abstracts at the 61st Annual Scientific Meeting of the American Headache Society (AHS) held July 11-14 in Philadelphia, PA.

MacroGenics, Inc. (NASDAQ: MGNX), and I-Mab Biopharma (I-Mab), a China and U.S.-based clinical-stage biopharmaceutical company committed to the discovery and development of first-in-class and best-in-class biologics in immuno-oncology and autoimmune diseases, announced today that the companies have entered into an exclusive collaboration and license agreement to develop and commercialize enoblituzumab.

The Health Coalition on Liability and Access announced its support of H.R. 3656, the Accessible Care by Curbing Excessive LawSuitS Act, a comprehensive medical liability reform bill introduced by Representative Richard Hudson.

Discovery Behavioral Health, Inc. announced the appointment of Jonathan Gross as National Director of Clinical Outreach for the Substance Use Disorder Division.